1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CTDSPL CTRPv2 pan-cancer AAC 0.23 3e-08
mRNA GPX1 CTRPv2 pan-cancer AAC 0.19 5e-08
mRNA TMEM105 CTRPv2 pan-cancer AAC 0.19 6e-08
mRNA NLRP3 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA OSBPL5 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA PRPS1 CTRPv2 pan-cancer AAC -0.19 1e-07
mRNA CECR6 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA GSDMA CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA PTPRE CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA GRAMD4 CTRPv2 pan-cancer AAC 0.19 3e-07
Download CSV